Khlo Kardashian, 37, was recently accused of misusing either Ozempic or Wegovy, with a troll writing beneath one of her Instagram snaps: The fact that she uses [diabetic] medicine to get this skinny is disturbing. Kardashian clapped back but didnt explicitly deny that she had ever tried the drugs
Real-world data published in PMC 2025 confirms that tirzepatide outperformed semaglutide on both HbA1c reduction and weight loss in head-to-head comparisons in actual patients not just clinical trials
Eli Lilly and Novo Nordisk are committing to offer Zepbound and Wegovy at Most Favored Nation rates for American patients
CVS Caremark Denial and Approval Rates: Although CVS does not publicly publish GLP-1 denial rates, industry sources provide clues
The experience varies person to person
For a subset of individuals, particularly those who are already sensitive to heart rate changes, it becomes noticeable